HistoSonics’ Edison platform uses focused ultrasound energy — delivered via a robotic arm — to for the noninvasive destruction of tumors.
Chris Newmarker is the Editor in Chief at Drug Delivery Business News. He covers a range of topics within medicine and healthcare, focusing on medical technology, engineering, and robotic engineering, with particular interest in medical equipment innovations, digital health, and telehealth. Chris's work has been featured in notable publications such as Medical Design & Outsourcing, The Robot Report, and MassDevice.
















